MDxHealth S.A.

NASDAQ:MDXH

Medical - Diagnostics & Research

Healthcare
$0.60 -4.45%

-$0.03 today

Market cap
$57.59M
Beta
0.38
P/E (TTM)
-1.0
EPS (TTM)
-$0.58
52W Low $0.40High $5.33

Volume 0.65M

Average 4.27M

MDXH Weighted Avg Shares (Diluted)

Average shares outstanding including dilutive securities, used to calculate diluted EPS.

MDxHealth S.A.NASDAQ: MDXH

Weighted Avg Shares (Diluted) · Q2 FY2026 · quarter ended Jun 2026

Weighted avg shares (diluted) grows 8.1% year over year

Q2 FY2026 weighted avg shares (diluted) of 52.42M shares rose 8.1% year over year. Over 3 fiscal years it compounded at +46.6% a year.

Context

  • Weighted avg shares (diluted) increased in 3 of the last 3 fiscal years.
  • FY2025 was the highest annual figure in the 4 fiscal years shown.

Sources:Income StatementText generated from reported figures; not investment advice.

Latest quarterJun 2026
52.42M— QoQ
Last fiscal yearDec 2025
50.03M+2.8% YoY
Weighted Avg Shares (Diluted) past and forecast growth by horizon
Horizon Past Forecast Difference
Quarter+8.1%——
1 year+2.8%——
3-year CAGR+46.6%——
5-year CAGR——
10-year CAGR——

Weighted Avg Shares (Diluted) history

Shares · from the income statement

Latest · FY2025
50.03M USD
Year-over-year change
+2.8%
4-year CAGR
+42.3%

Weighted Avg Shares (Diluted) vs competitors

How MDXH compares with its peers on the latest reported figures

  • MDXH's FY2025 weighted avg shares (diluted) of 50.03M shares is the 5th highest of the 11 companies compared; the peer median is 42.8M shares.
  • Its year-over-year change of +2.8% is the 10th highest of 11, against a peer median of +26.0%.
  • Over three fiscal years its annual growth of +46.6% compares with a peer median of +18.6%.
MDXH Competitors Peer median
Weighted Avg Shares (Diluted) for MDXH and competitors
Company Period LTM YoY 3-year CAGR
NEONeoGenomics, Inc.LTM Jun 2026129.14M +1.5%+1.0%
ACRSAclaris Therapeutics, Inc.LTM Mar 2026124.17M +37.8%+23.4%
ZURAZura Bio LimitedLTM Mar 202698.81M +34.9%+76.1%
STXSStereotaxis, Inc.LTM Mar 202693.68M +8.6%+6.1%
MDXHMDxHealth S.A.FY202550.03M +2.8%+46.6%
QTRXQuanterix CorporationLTM Mar 202644.68M +16.0%+4.9%
IMRXImmuneering CorporationLTM Mar 202640.92M +29.8%+18.6%
XGNExagen Inc.LTM Mar 202622.36M +22.2%+8.1%
SIShoulder Innovations, Inc.LTM Mar 202620.52M +3.0%—
ASMBAssembly Biosciences, Inc.LTM Mar 202610.86M +66.5%+40.6%
SNWVSANUWAVE Health, Inc.LTM Mar 20269M +86.9%+83.7%
Peer median (excluding MDXH) 42.8M+26.0%+18.6%

Competitors are the stored peer set for MDXH. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.

Income Statement

USD
Metric
FY2021
Dec 2021
FY2022
Dec 2022
FY2023
Dec 2023
FY2024
Dec 2024
FY2025
Dec 2025
Revenue22.24M37.05M70.19M90.05M107.88M
Cost of Revenue11.68M17.84M26.26M34.91M43.43M
Gross Profit10.56M19.22M43.93M55.14M64.44M
Gross Margin47.5%51.9%62.6%61.2%59.7%
Research & Development5.59M7.56M6.38M10.55M10.35M
Selling, General & Admin30.22M50.12M59.93M61.4M66.75M
Operating Expenses37.41M57.12M71.26M79.86M79.84M
Depreciation & Amortization3.04M4.91M6.86M8.04M9.21M
EBITDA(24.09M)(36.39M)(30.47M)(22.02M)(14.01M)
EBITDA Margin-108.3%-98.2%-43.4%-24.5%-13.0%
Operating Income(26.84M)(37.9M)(27.33M)(24.72M)(15.4M)
Operating Margin-120.7%-102.3%-38.9%-27.5%-14.3%
Interest Income11K125K1.09M1.08M1.5M
Interest Expense1.88M2.74M5.77M7.63M12.16M
Other Income / Expenses(2.16M)(6.14M)(15.77M)(12.97M)(19.98M)
Income Before Tax(29M)(44.04M)(43.1M)(37.69M)(35.38M)
Pre-Tax Margin-130.4%-118.9%-61.4%-41.9%-32.8%
Income Tax Expense001K382K(1.86M)
Net Income(29M)(44.04M)(43.1M)(38.07M)(33.52M)
Net Margin-130.4%-118.9%-61.4%-42.3%-31.1%
EPS (Basic)(2.38)(2.78)(1.66)(0.78)(0.67)
EPS (Diluted)(2.38)(2.78)(1.66)(1.16)(0.67)
Weighted Avg Shares12.19M15.87M25.91M48.67M50.03M
Weighted Avg Shares (Diluted)12.19M15.87M25.91M48.67M50.03M

MDxHealth S.A.

NASDAQ:MDXH

Intrinsic Alpha fair value

Locked

Current Price

$0.60

Margin of safety hidden

Unlock the intrinsic value to see where the current price sits on the valuation runway.

Valuation runway

Locked

Get the intrinsic value and margin of safety with a free account.